Cancer Technology and Treatment

Technology and Treatments

Advanced and comprehensive. Close to home.

At Ingalls Cancer Care, the best technology and treatments are always within reach. Through locations in Harvey, Tinley Park and Flossmoor, Ingalls offers the most advanced and comprehensive technology in Chicago's south suburbs, making it easy to receive treatment locally. In fact, Ingalls was the first hospital in the south suburbs to offer Intensity Modulated Radiation Therapy (IMRT), which selectively radiates tumors while protecting surrounding healthy tissue. Our patients enjoy the best technology available including IMRT, IGRT, PET/CT scanning, digital mammography, and a host of minimally invasive cancer treatment therapies like chemoembolization, radiofrequency ablation (RFA), cryoablation and Selective Internal Radiation Therapy (SIRT).

What's more, our doctors are constantly improving the standard of care for cancer treatment. Ingalls cancer specialists work together with experts from across the nation, with the entire Ingalls cancer team, and with you to deliver the most comprehensive diagnostics, treatment, and rehabilitative care in the south suburbs.

When surgery is the first line of attack

Our board-certified surgeons offer surgical treatments for nearly every type of cancer. Advanced surgical techniques include minimally invasive procedures that remove tumors while preserving as much normal function as possible. When necessary, reconstructive surgery is also available by board-certified reconstructive surgeons. After surgery, every Ingalls cancer patient enjoys the comfort and security of a private hospital room. And Ingalls provides a suite of cancer comfort services through a unique partnership with Faye's Light, a local cancer comfort care provider. Weekly massages, facials and manicures are completely free to Ingalls cancer inpatients.

Cancer treatment with fewer side effects

One myth surrounding cancer therapy is that the side effects of treatment can be worse than the disease. Today, we are reducing the side effects of treatment by precisely targeting tumors while protecting healthy tissue. Chemotherapy is better tolerated. Therapies are completed faster and more effectively than ever before. And because Ingalls is focused on individualized care, we provide the resources patients need to fight, win, and move on with their lives. For your added convenience, we offer comprehensive infusion services at the Ingalls Outpatient Infusion Centers located at the main hospital campus in Harvey, and at our Family Care Centers in Tinley Park and Flossmoor.

Moving beyond cancer's grip

People would like to beat their cancer and pick up right where they left off. But life after cancer isn't always that simple, so Ingalls provides support services to help cancer patients and their loved ones cope with the emotional, psychological and social effects of cancer. Through our collaboration with the Cancer Support Center in Homewood, Ingalls provides a dedicated resource library, screenings and education, individual and family counseling, exercise and wellness programs, stress management, expressive arts, nutrition classes, social events, support groups, and grief support. For patients recovering from breast cancer treatment, Ingalls has the area's only STAR-certified Cancer Rehabilitation Program, which hastens recovery, and improves comfort and quality of life for each patient. And, Ingalls offers a variety of complementary medicine treatments such as acupuncture, yoga, massage and more through the Ingalls Wellness Center in -Flossmoor.

And to ensure the maximum number of quality years for our cancer survivors, Ingalls offers a comprehensive survivorship program. The program is coordinated by an advanced practice nurse/nurse navigator and offers a survivorship care plan, personal and customized education, medical surveillance guidelines, directed navigation to health professional services, survivorship seminars and workshops and resources.

Here are some of the additional support services available to cancer patients and survivors:

  • Faye's Light

    Faye's Light is a not-for-profit organization that provides quality-of-life services to those currently undergoing treatment for cancer. These services complement medical care and include holistic treatments and spa services, with a focus on mind, body, and spirit...all at no cost to the recipient. Visit Faye’s light website at http://www.fayeslight.org/.

  • Cancer Support Center

    The Jennifer S. Fallick Cancer Support Center in Homewood was formed in 1994, when six Southland women worked together to open a home-like center (with location in Homewood) for people in more than 70 Chicago southland and Northwest Indiana communities.

    The Center provides services free of charge to a diverse participant base including cancer patients, caregivers, children, teens and friends of the cancer patient. In addition to support groups, individual and family counseling sessions and the Center’s comprehensive Resource Center, wellness programs are offered on a weekly basis. Participants enjoy yoga, qi gong, meditation, relaxation and massage therapy. On average, the Center staff responds to more than 300 calls or visits to the Homewood location. Visit the Cancer Support Center's website at http://www.cancersupportcenter.org/.

  • Breast Cancer Rehabilitation Program

    Today’s life-saving cancer treatments may cause side effects that require physical rehabilitation to help patients manage their pain, regain certain abilities and restore their quality of life. That’s why Ingalls has created the area’s only Breast Cancer Rehabilitation Program.

    The Ingalls program is based on well-documented research that shows exercise and other therapy interventions can help:

    • Reduce fatigue and depression
    • Maintain weight, muscle mass and range of motion
    • Promote strength and flexibility
    • Restore balance
    • Eliminate pain
    • Improve quality of life.

    The cancer rehabilitation team at Ingalls includes highly skilled physical therapists trained and certified in lymphedema treatment, occupational therapists, physicians, nurses and other clinical specialists who understand the unique needs of people undergoing treatment for and recovering from cancer.

  • Ingalls Wellness Center

    Located at the Flossmoor Family Care Center, the Ingalls Wellness Center provides a full range of complementary medicine treatment to offer patients relief from pain, increased flexibility, an alternative to surgery or a supplement before or after surgery. Services include , yoga, smoking cessation, hypnotherapy, acupuncture, massage therapy, reflexology and aromatherapy.

  • Comprehensive Infusion Services

    Through the Ingalls Outpatient Infusion Centers, located at our main hospital campus in Harvey, and at Ingalls Family Care Centers in Tinley Park and Flossmoor, Ingalls offers comprehensive infusion therapies for a wide variety of patients, including patients undergoing chemotherapy for cancer treatment. All infusion treatments are given by our specially trained infusion nurses in a comfortable setting, complete with recliner chairs, televisions, headphones and more.

Quality of Patient Care Reports

Ingalls CP3R Performace Rate ComparisonsIngalls Memorial Hospital Cancer Program continuously monitors the quality of patient care provided for all cancer diagnoses. Additionally, through the American College of Surgeons (ACoS) Commission on Cancer’s (CoC) web-based quality reporting tool – Cancer Programs Practice Profile Reports (CP3R) – Ingalls Memorial Hospital Cancer Program monitors specific standard – of – care measures related to breast and colon cancer. These accountability measures have been endorsed by the National Quality Forum (NQF) and are used to both improve the quality of data collected for these disease sites and the clinical management and coordination of patient care in the multidisciplinary care setting.

The four quality measures are:

  • BCS (Breast Conserving Surgery) – Radiation therapy is administered within one year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer.
  • MAC (Multiagent Chemotherapy) – Combination chemotherapy is considered or administered within four months (120 days) of diagnosis for women under age 70 with T1cN0M0, or Stage II or III hormone receptor negative breast cancer.
  • HT (Hormone Therapy) Tamoxifen or third generation aromatase inhibitor is considered or administered within one year (365 days) of diagnosis for women with T1cN0M0, or Stage II or III hormone receptor positive breast cancer.
  • ACT (Adjuvant Chemotherapy) – Adjuvant chemotherapy is considered or administered within four months (120 days) of diagnosis for patients under the age of 80 with Stage III (lymph node positive) colon cancer.

The above chart shows that a higher percentage of patients with breast and colon cancer treated at Ingalls Memorial Hospital receive care according to these standards when compared with CoC hospitals in Illinois as well as nationwide.

The CP3R is a dynamic, web-based tool that can be accessed at any time by cancer programs to update their data and therefore, the comparison data shown above is subject to change at any time.

Cancer Care at Ingalls Video

Better Outcomes. Fewer Side Effects.

View Video

Clinical Trials

Breast

Clinical Trial #: NSABP B-43 (NCT 00769379)

Read More

Colon/Rectal Stage III

Clinical Trial #: CALGB 80702 (NCT 01150045)

Read More

Head and Neck Stage II - Stage III

Clinical Trial #: RTOG 0920 (NCT 00956007)

Read More

Head and Neck Stage IV

Clinical Trial #: U of C 09-266-B (NCT 01111058)

Read More

Head and Neck

Clinical Trial #: ECOG E1305 (NCT 00588770)

Read More

Hepatocellular Stage II - Stage III

Clinical Trial #: ECOG E1208 (NCT 01004978)

Read More

Lung (small cell) Stage IV

Clinical Trial #: RTOG 0937 (NCT 01055197)

Read More

Lymphoma

Clinical Trial #: U of C 09-443-A (NCT 01076543)

Read More

Pancreas

Clinical Trial #: RTOG 0848 (NCT 01013649)

Read More

Prostate Stage I- Stage III

Clinical Trial #: RTOG 0534 (NCT 00567580)

Read More

Lung (non-small cell) Stage III

Clinical Trial #: ECOG E6508 (NCT 00828009)

Read More

Breast Stage IV

Clinical Trial #: ECOG 2108 (NCT 01242800)

Read More

Breast Stage I- Stage III

Clinical Trial #: SWOG S1007 (NCT 01272037)

Read More

Breast Stage I- Stage III

Clinical Trial #: NSABP B-47 (NCT 01275677)

Read More

Melanoma Stage III- Stage IV

Clinical Trial #: ECOG E1609 (NCT 01274338)

Read More

Thyroid

Clinical Trial #: U of C 10-182-B (NCT 01208051)

Read More

Gastric Stage IIA- Stage IIIA

Clinical Trial #: RTOG 1010 (NCT 01196390)

Read More

Lymphoma

Clinical Trial #: Abbott M12-630 (NCT 01594229)

Read More

Prostate Stage IV

Clinical Trial #: U of C 11-0709 (NCT 01543776)

Read More

Lymphoma Stage III- Stage IV

Clinical Trial #: CALGB 50904 (NCT 01286272)

Read More

Head and Neck Stage III- Stage IV

Clinical Trial #: Boehringer Ingelheim 1200.131 (NCT 01345669)

Read More

Breast

Clinical Trial #: Alliance A221102 (NCT 01573442)

Read More

Lung (small cell)

Clinical Trial #: U of C 12-1726 (NCT 01803269)

Read More

Melanoma Stage III- Stage IV

Clinical Trial #: ECOG E3611 (NCT 01708941)

Read More

Colon/Rectal

Clinical Trial #: Genentech/Roche ML28442 (NCT 01765582)

Read More

Breast

Clinical Trial #: ACOSOG Z11102 (NCT 01556243)

Read More

Colon/Rectal Stage IIA - Stage IIIB

Clinical Trial #: Alliance N1048 (NCT 01515787)

Read More

Endometrial/Cervical

Clinical Trial #: RTOG 1203 (NCT 01672892)

Read More

Breast Stage I - Stage IIIA

Clinical Trial #: NSABP B51/ RTOG 1304 (NCT 01872975)

Read More

Breast

Clinical Trial #: SWOG S1207 (NCT 01674140)

Read More

Breast Stage IV

Clinical Trial #: PUMA-NER-1301 (NCT 01808573)

Read More

Breast

Clinical Trial #: ECOG E1Z11 (NCT 01824836)

Read More

Carcinoid

Clinical Trial #: Alliance A021202 (NCT 01841736)

Read More

Pancreas Stage IV

Clinical Trial #: SCRI GI184 (NCT 01844817)

Read More

Lymphoma Stage II, III, or IV

Clinical Trial #: ECOG E1412 (NCT 01856192)

Read More

Breast Stage I - Stage II

Clinical Trial #: Alliance A011104 (NCT 01805076)

Read More

Pancreas Stage II, III, or IV

Clinical Trial #: U of C 13-0233 (NCT 01585805)

Read More

Breast Stage IV

Clinical Trial #: Novartis CLEE011A2301 (NCT 01958021)

Read More

Leukemia

Clinical Trial #: Roche GO28667 (NCT 02005471)

Read More

Lung (non-small cell) Stage IIIB - Stage IV

Clinical Trial #: Roche GO28915 (NCT 02008227)

Read More

Breast Stage IIA - Stage IIIC

Clinical Trial #: Alliance A011106 (NCT 01953588)

Read More

Multiple Myeloma

Clinical Trial #: SWOG S1211 (NCT 01668719)

Read More

Breast Stage IB- Stage IIIA

Clinical Trial #: Alliance A011202 (NCT 01901094)

Read More

Breast

Clinical Trial #: SWOG S1202 (NCT 01598298)

Read More

Leukemia

Clinical Trial #: Genentech GO28440 (NCT 01671904)

Read More

Breast

Clinical Trial #: Celldex Therapeutics CDX011-04 (NCT 01997333)

Read More

Bladder Stage IV

Clinical Trial #: Roche GO29293 (NCT 02108652)

Read More

Breast

Clinical Trial #: Genomic Health 14-002

Read More

Pancreas

Clinical Trial #: Incyte 18424-363

Read More

Breast Stage III- Stage IV

Clinical Trial #: ECOG E2112

Read More

Lung (non-small cell) Stage IV

Clinical Trial #: SCRI LUN261

Read More

Lymphoma

Clinical Trial #: Roche/Abbvie BO29337

Read More

Lung (non-small cell) Stage IIIB - Stage IV

Clinical Trial #: Abbvie M11-089

Read More

Prostate Stage IV

Clinical Trial #: Alliance A031201

Read More

Breast Stage IB - Stage III

Clinical Trial #: NSABP B52

Read More

Success Stories

Ingalls Among First in Nation to Offer Investigative Drug for Leukemia

Unique Liver Tumor Treatment Provides Hope for South Side Native

Read More

Proper Nutrition is a Must for Cancer Patients

Read More

'Accidental Find' of Melanoma Saves Park Forest Woman

Read More

Our Experts Take Cancer Care Personally

Read More

Ingalls Honored for Outstanding Cancer Achievement

Read More

Dolton Man Faces Lung Cancer with a Positive Attitude

Read More

Ingalls Doctors Put the ‘Deep Freeze’ on Tumors and Save Patient’s Kidneys

Read More

Ingalls Introduces Ambassadors for Cancer Research

Read More

Ingalls Enrolling Patients in National Pancreatic Cancer Study

Read More

Chicago Woman is 'Poster Child' for Successful Breast Cancer Treatment

Read More

Helping Cancer Survivors Triumph Over Stress and Depression

Read More

New Therapy for Patients with Inoperable Liver Cancer

Read More

Rogers & Hollands Jewelers Promise of Hope.

The Rogers & Hollands Jewelers ‘Promise of Hope Collection’ was inspired by company matriarch, Juell Kadet. As a 30-year cancer survivor, she has been at the forefront of raising funds for cancer research to further Ingalls Hospital's Cancer Care Clinical Trials.

When purchasing a Promise of Hope piece, 20% of the net proceeds from your purchase are donated to the Cancer Care Clinical Trials at Ingalls Hospital.

To view the collection, visit: Promise of Hope.

Ingalls Resources

Other Resources